Signaling pathways responsible for cancer cell invasion as targets for cancer therapy

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Cancer cell migration is a critical factor in metastasis.
• Highly invasive cancers exhibit aberrant molecular activity, including protein kinases and transcription factors.
• Understanding these mechanisms can identify therapeutic targets for invasive cancers.

Purpose of the Study:

• To review strategies for targeting molecular signaling pathways involved in cancer invasion and metastasis.
• To highlight the role of specific molecules in promoting invasive phenotypes.

Main Methods:

• Review of literature on signaling pathways in cancer metastasis.
• Analysis of the roles of Protein Kinase C (PKC) and phosphatidylinositol 3-kinase (PI3K) in cancer cell invasion.
• Examination of the NF-kappaB and AP-1 transcription factors and their downstream targets, uPA and uPAR.

Main Results:

• PKC and PI3K signaling contribute to constitutive activity of NF-kappaB and AP-1 in invasive cancers.
• NF-kappaB and AP-1 regulate the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR).
• Inhibition of PKC and PI3K signaling suppressed uPA secretion, reducing breast cancer cell motility.

Conclusions:

• Targeting common signaling pathways involved in metastasis holds clinical potential.
• Inhibiting PKC and PI3K signaling can reduce the motility of highly invasive cancer cells.
• Identifying and targeting specific molecules in metastatic pathways is crucial for cancer treatment.